Literature DB >> 3534838

Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy.

J M Criley, R J Siegel.   

Abstract

There has been a longstanding controversy about the significance of intracavitary pressure gradients in hypertrophic cardiomyopathy (HCM). It has been generally assumed that the gradient is the result of an 'obstruction' that impedes left ventricular outflow and which can be relieved by operative intervention. In the first decade after the discovery of HCM (1957-66), the site of 'obstruction' was thought to be a muscular sphincter or contraction ring in the submitral region of the left ventricle, and operations designed to emulate pyloromyectomy (for hypertrophic pyloric stenosis) were developed. Following a challenge to the existence of the 'contraction ring' and an alternative non-obstructive explanation of the pressure gradient, the site of 'obstruction' was translocated to a point of apposition between the anterior mitral leaflet and the interventricular septum, a result of systolic anterior motion (SAM) of the mitral valve. Despite the translocation of the site and mechanism of 'obstruction', the operation for 'relief of obstruction' has not changed significantly. The newer site of 'obstruction' has been challenged on the grounds that the ventricle is not demonstrably impeded in its emptying; when a gradient is provoked, the ventricle empties more rapidly and more completely than it does without a gradient. In addition to a non-obstructive explanation of the gradient, other phenomena thought to be indicative of 'obstruction' can be explained by rapid and complete emptying of the ventricle (cavitary obliteration). Since the morbidity and mortality of symptomatic HCM patients without pressure gradients may exceed that of patients with pressure gradients, it is suggested that 'obstruction' may be unimportant in the pathophysiology of HCM and attention should be focused on abnormal diastolic function and life threatening arrhythmias.

Entities:  

Mesh:

Year:  1986        PMID: 3534838      PMCID: PMC2418802          DOI: 10.1136/pgmj.62.728.515

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  47 in total

1.  Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients.

Authors:  A G Morrow; B A Reitz; S E Epstein; W L Henry; D M Conkle; S B Itscoitz; D R Redwood
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

2.  Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study.

Authors:  J E Sanderson; D G Gibson; D J Brown; J F Goodwin
Journal:  Br Heart J       Date:  1977-06

3.  Left ventricular volumes and compliance in hypertrophic cardiomyopathy.

Authors:  M S Gotsman; B S Lewis
Journal:  Chest       Date:  1974-11       Impact factor: 9.410

4.  Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis.

Authors:  W L Henry; C E Clark; D L Glancy; S E Epstein
Journal:  N Engl J Med       Date:  1973-05-10       Impact factor: 91.245

5.  Diffuse muscular subaortic stenosis: surgical treatment.

Authors:  D A Cooley; R D Leachman; D C Wukasch
Journal:  Am J Cardiol       Date:  1973-01       Impact factor: 2.778

6.  Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history.

Authors:  S Frank; E Braunwald
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

7.  Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy.

Authors:  P M Shah; R Gramiak; D H Kramer
Journal:  Circulation       Date:  1969-07       Impact factor: 29.690

8.  The bottom line syndrome. Hypertrophic cardiomyopathy revisited.

Authors:  J M Criley
Journal:  West J Med       Date:  1979-04

9.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.

Authors:  D D Savage; S F Seides; B J Maron; D J Myers; S E Epstein
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

10.  Echocardiographic spectrum of hypertrophic cardiomyopathy.

Authors:  O Feizi; R Emanuel
Journal:  Br Heart J       Date:  1975-12
View more
  2 in total

1.  Ventricular dysfunction in hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1991

Review 2.  Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Authors:  Daniel J Philipson; Eugene C DePasquale; Eric H Yang; Arnold S Baas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.